IL-1 blockade with anakinra demonstrated favorable trends in high-sensitivity CRP and NT-proBNP levels among obese patients with heart failure with preserved ejection fraction.
Absolute Event Rate: 0% vs 0%
slope in a group of obese heart failure with preserved ejection fraction patients. The favorable trends in high-sensitivity CRP and NT-proBNP with anakinra deserve exploration in future studies. Clinical Trial Registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT02173548.
Tassell et al. (Wed,) reported a other. IL-1 blockade with anakinra demonstrated favorable trends in high-sensitivity CRP and NT-proBNP levels among obese patients with heart failure with preserved ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: